PLoS ONE (Jan 2013)

Estimated incidence and genotypes of HIV-1 among pregnant women in central Brazil.

  • Zelma Bernardes Costa,
  • Mariane Martins de Araujo Stefani,
  • Yanna Andressa Ramos de Lima,
  • Wayner Vieira de Souza,
  • Noemia Teixeira de Siqueira Filha,
  • Marilia Dalva Turchi,
  • Walter Costa Borges,
  • Clidenor Gomes Filho,
  • Jose Vicente Macedo Filho,
  • Ana Lucia Minuzzi,
  • Celina Maria Turchi Martelli

DOI
https://doi.org/10.1371/journal.pone.0079189
Journal volume & issue
Vol. 8, no. 11
p. e79189

Abstract

Read online

OBJECTIVE: To estimate the incidence of HIV-1 infection among pregnant women from central-western Brazil. DESIGN: Observational cross-sectional study. METHODS: A total of 54,139 pregnant women received antenatal HIV screening from a network of public healthcare centers in 2011. The incidence of confirmed HIV-1 infection was estimated using the Serological Testing Algorithms for Recent HIV Seroconversion (STARHS) methodology and BED-capture enzyme immunoassay (BED-CEIA). The yearly incidence was calculated, and adjusted incidence rates were estimated. For a subgroup of patients, protease and partial reverse transcriptase regions were retrotranscribed from plasma HIV-1 RNA and sequenced after performing a nested polymerase chain reaction. RESULTS: Of the participants, 20% had a pregnancy before the age of 18 and approximately 40% were experiencing their first pregnancy. Of the 54,139 pregnant women screened, 86 had a confirmed HIV-1 diagnosis, yielding an overall prevalence of 1.59 cases per 1000 women (95% CI 1.27-1.96). A higher prevalence was detected in the older age groups, reflecting cumulative exposure to the virus over time. Among the infected pregnant women, 20% were considered recently infected according to the BED-CEIA. The estimated incidence of HIV infection was 0.61 per 1000 person-years (95% CI 0.33-0.89); the corrected incidence was 0.47 per 1000 person-years (95% CI 0.26-0.68). In a subgroup of patients, HIV-1 subtype C (16.7%) was the second most prevalent form after subtype B (66.7%); BF1 recombinants (11.1%) and one case of subtype F1 (5.5%) were also detected. CONCLUSION: This study highlights the potential for deriving incidence estimates from a large antenatal screening program for HIV. The rate of recent HIV-1 infection among women in their early reproductive years is a public health warning to implement preventive measures.